Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Alethia Young
Recent news which mentions Alethia Young
Regeneron Requests Emergency Use Authorization, Analysts See Coronavirus Antibodies As Earnings Driver In 2021
October 08, 2020
Tickers
GILD
LLY
REGN
Tags
Donald Trump
News
Coronavirus
From
Benzinga
Why Regeneron's Growth Opportunity Is Unappreciated
October 05, 2020
Tickers
NVS
REGN
Tags
Health Care
Alethia Young
Trading Ideas
From
Benzinga
Gilead Analysts Dissect Immunomedics Deal: 'Pricier But Bold Move Into Oncology'
September 14, 2020
Tickers
AZN
GILD
IMMU
Tags
Alethia Young
H/C/ Wainwright
Geoffrey Porges
From
Benzinga
Gilead Analysts Downplay Q2 Miss Amid Remdesivir's COVID-19 Opportunity
July 31, 2020
Tickers
GILD
Tags
Alethia Young
Geoffrey Porges
Morgan Stanley
From
Benzinga
Why Shares Of Spectrum Pharma Are Ripping Higher
July 28, 2020
Tickers
SPPI
Tags
Analyst Color
Analyst Ratings
Reiteration
From
Benzinga
5 ASCO Abstracts Moving Biopharma Stocks
May 14, 2020
Tickers
ALLO
AMGN
ARVN
CTMX
Tags
Robert Burns
Top Stories
American Society of Clinical Oncology
From
Benzinga
Gilead Analyst Sees Over 50% Chance Of Success For Remdesivir In Mild-To-Moderate COVID-19
April 07, 2020
Tickers
FTSV
GILD
Tags
coronavirus
GILD
Market News
From
Benzinga
Gilead Analyst Sees Catalyst Ahead In Data Readout For Potential Coronavirus Treatment
April 06, 2020
Tickers
GILD
Tags
Analyst Color
Analyst Ratings
Market News
From
Benzinga
Biogen Analysts Divided Over Alzheimer's Drug Following CTAD Presentation
December 06, 2019
Tickers
BIIB
Tags
Alethia Young
H/C/ Wainwright
Cantor Fitzgerald
From
Benzinga
Biogen's CTAD Presentation On Aducanumab Elicits Mixed Response
December 05, 2019
Tickers
BIIB
Tags
Reiteration
Benzinga
Market News
From
Benzinga
Is Intercept Pharma's Updated Late-Stage NASH Data A Sell-The-News Event?
April 11, 2019
Tickers
ICPT
UBS
Tags
Trading Ideas
Alethia Young
UBS
From
Benzinga
Cantor Fitzgerald Bumps Puma Biotechnology Price Target On Strong Nerlynx Sales
March 01, 2019
Tickers
PBYI
Tags
Benzinga
Reiteration
Price Target
From
Benzinga
Analysts Laud Sarepta's 'Increasingly Active' Gene Therapy Clinical Development
February 28, 2019
Tickers
SRPT
Tags
Janney
Market News
Price Target
From
Benzinga
Viking Has A More Attractive M&A Valuation Than Madrigal, Raymond James Says In Upgrade
November 19, 2018
Tickers
MDGL
VKTX
Tags
Joseph Pantginis
Upgrades
Steven Seedhouse
From
Benzinga
Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse Bearish
March 22, 2018
Tickers
MESO
TEVA
Tags
Alethia Young
Downgrades
TEVA
From
Benzinga
Credit Suisse: Celgene Needs To Win Back Investor Trust
February 28, 2018
Tickers
CELG
Tags
Price Target
Benzinga
Reiteration
From
Benzinga
Credit Suisse: Street Expectations 'Too High' For Gilead's Hep C Therapy
December 20, 2017
Tickers
GILD
Tags
Downgrades
Hepatitis C
Analyst Ratings
From
Benzinga
U.S. Approval Of PTC Therapeutics' Translarna 'Remains Unlikely'
September 29, 2017
Tickers
NEWS
PTCT
SRPT
Tags
Benzinga
PTCT
Analyst Color
From
Benzinga
Credit Suisse Weighs In Ahead Of PTC Therapeutics' Thursday AdCom Panel For Translarna
September 26, 2017
Tickers
NEWS
PTCT
SRPT
Tags
Biotech
Movers
Previews
From
Benzinga
A Veteran CEO Might Be Just What Sarepta Therapeutics Needed
June 29, 2017
Tickers
SRPT
Tags
Credit Suisse
Reiteration
Benzinga
From
Benzinga
C-Suite Shake Up: How Paul Clancy Jumping Ship Affects Alexion, Biogen
June 15, 2017
Tickers
ALXN
BIIB
NEWS
Tags
News
Credit Suisse
Reiteration
From
Benzinga
How analysts are interpreting Biogen's management shakeup
June 14, 2017
Tickers
BIIB
Tags
Alexion Pharmaceuticals
Salim Syed
Jean/Paul Kress
From
Business Journals
3 Takeaways From Monday's ASCO Meetings: Puma Biotech, Incyte, Celgene
June 06, 2017
Tickers
CELG
INCY
PBYI
Tags
General
CELG
Analyst Color
From
Benzinga
Is The FDA Panel Vote On Puma Biotech Likely To Lead To Actual Approval?
May 25, 2017
Tickers
NEWS
PBYI
Tags
FDA
Puma Biotechnology
PB272
From
Benzinga
Analysts On Gilead: We Think They're Mobilizing For A Deal
May 04, 2017
Tickers
GILD
NEWS
Tags
Biotech
Eliana Merle
General
From
Benzinga
Gilead Looking To Buy Incyte? It Makes Sense
March 14, 2017
Tickers
GILD
INCY
KITE
NEWS
Tags
News
KITE
Reiteration
From
Benzinga
Stay Of Court Injunction A Mild Positive For Regeneron
February 09, 2017
Tickers
AMGN
NEWS
REGN
SNY
Tags
Reiteration
Benzinga
Credit Suisse
From
Benzinga
Credit Suisse Says Sarepta Shares Volatile, Still A Favorite Idea
January 05, 2017
Tickers
DMD
NEWS
SRPT
Tags
Duchenne Muscular Dystrophy
DMD
General
From
Benzinga
Biogen's Spinraza Could Cost $125,000 Per Dose
December 29, 2016
Tickers
BIIB
IONS
Tags
General
Nusinersen
Biotech
From
Benzinga
Alexion Management On Internal Investigation: So Far, So Good
November 10, 2016
Tickers
ALXN
Tags
Long Ideas
Alethia Young
Legal
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.